COVID-19: Clinical Advances and Challenges

This SI reprint comprehensively explores the ongoing COVID-19 pandemic, addressing various facets, from treatment protocols to global health implications. This 30-article reprint reflects the breadth and depth of the medical community's response to this unprecedented health crisis. Each article brin...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
स्वरूप: Online
भाषा:अंग्रेज़ी
प्रकाशित: MDPI - Multidisciplinary Digital Publishing Institute 2024
विषय:
n/a
CKD
age
ऑनलाइन पहुंच:ONIX_20240514_9783036598390_46
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
_version_ 1869518397995220992
collection Directory of Open Access Books
description This SI reprint comprehensively explores the ongoing COVID-19 pandemic, addressing various facets, from treatment protocols to global health implications. This 30-article reprint reflects the breadth and depth of the medical community's response to this unprecedented health crisis. Each article brings a unique perspective, contributing to a multifaceted understanding of the pandemic. Topics range from innovative therapeutics and vaccine development to the impact of COVID-19 on different patient populations and healthcare systems globally. This SI includes research articles, reviews, and communications that highlight the rapid advancements in understanding and managing COVID-19 and the challenges faced by healthcare professionals and researchers. One of the notable features of this SI is its focus on the evolving nature of the disease and responses to it. Articles discuss the efficacy of various treatment methods against emerging virus variants, providing crucial insights for ongoing and future pandemic preparedness. This SI also sheds light on the real-world experiences of healthcare providers, patients, and policymakers, offering a holistic view of the pandemic's impact. It is an essential resource for healthcare professionals, researchers, and policymakers. It underscores the importance of high-quality, rapid research in response to global health emergencies and fosters a collaborative approach to overcoming the challenges posed by COVID-19. These articles contribute to the current understanding of the pandemic and lay a foundation for future research and response strategies in the face of similar global health threats.
format Online
id doab-20.500.12854ir-137444
institution Directory of Open Access Books
language eng
publishDate 2024
publishDateRange 2024
publishDateSort 2024
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-1374442024-05-14T13:06:32Z COVID-19: Clinical Advances and Challenges Arora, Shitij Palaiodimos, Leonidas COVID-19 SARS-CoV-2 ciclesonide inhalation antiviral agents remdesivir pneumonia non-invasive ventilation mechanical ventilation COVID-19 vaccine ChAdOx1-S BNT162b2 immunogenicity anakinra baricitinib corticosteroids mortality COVID-19 therapeutics immunomodulatory treatment meta-analysis updated bamlanivimab etesevimab hospital admission thromboembolism tocilizumab hydroxycholoroquine immunomodulation anticoagulation dose thromboprophylaxis treatment lung ultrasound COVID-19 pneumonia imaging radiology computed tomography safety adverse events acute kidney injury nephrotoxicity antibiotics antibacterial agents mixed methods qualitative quantitative mucormycosis fungal infection risk factors diagnosis therapeutics omicron coronavirus disease 2019 monoclonal antibodies Casirivimab plus imdevimab Sotrovimab bebtelovimab molnupiravir paxlovid evusheld Anakinra timeline n/a long COVID SPECT HR-CT scan lung function test dosage biomarker Krebs von den Lungen-6 severity children pandemic waves hospitalization clinical presentation coronavirus steroids early remdesivir ritonavir-boosted nirmatrelvir sotrovimab hematological patients hospitalizations rate prolonged viral shedding bromhexine standard of care viral load primary care SARS-CoV-2 vaccine cellular response CKD humoral responses thrombosis risk prediction model clinical prediction rule Coronavirus Disease-2019 (COVID-19) post-acute sequelae of SARS CoV-2 (PASC, long COVID, post-COVID conditions) phenome-wide association study phenotype risk score electronic health records post-acute sequelae sex hormones age antibodies cellular immunity humoral immunity INF-γ release assay mRNA vaccine machine learning gradient boosting classifier reinfection taste dysfunction smell perception central nervous system predictors of mortality thema EDItEUR::M Medicine and Nursing This SI reprint comprehensively explores the ongoing COVID-19 pandemic, addressing various facets, from treatment protocols to global health implications. This 30-article reprint reflects the breadth and depth of the medical community's response to this unprecedented health crisis. Each article brings a unique perspective, contributing to a multifaceted understanding of the pandemic. Topics range from innovative therapeutics and vaccine development to the impact of COVID-19 on different patient populations and healthcare systems globally. This SI includes research articles, reviews, and communications that highlight the rapid advancements in understanding and managing COVID-19 and the challenges faced by healthcare professionals and researchers. One of the notable features of this SI is its focus on the evolving nature of the disease and responses to it. Articles discuss the efficacy of various treatment methods against emerging virus variants, providing crucial insights for ongoing and future pandemic preparedness. This SI also sheds light on the real-world experiences of healthcare providers, patients, and policymakers, offering a holistic view of the pandemic's impact. It is an essential resource for healthcare professionals, researchers, and policymakers. It underscores the importance of high-quality, rapid research in response to global health emergencies and fosters a collaborative approach to overcoming the challenges posed by COVID-19. These articles contribute to the current understanding of the pandemic and lay a foundation for future research and response strategies in the face of similar global health threats. 2024-05-14T13:06:18Z 2024-05-14T13:06:18Z 2024 book ONIX_20240514_9783036598390_46 9783036598390 9783036598406 https://directory.doabooks.org/handle/20.500.12854/137444 eng application/octet-stream Attribution-NonCommercial-NoDerivatives 4.0 International https://mdpi.com/books/pdfview/book/8598 https://mdpi.com/books/pdfview/book/8598 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-9840-6 10.3390/books978-3-0365-9840-6 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036598390 9783036598406 408 open access
spellingShingle COVID-19
SARS-CoV-2
ciclesonide
inhalation
antiviral agents
remdesivir
pneumonia
non-invasive ventilation
mechanical ventilation
COVID-19 vaccine
ChAdOx1-S
BNT162b2
immunogenicity
anakinra
baricitinib
corticosteroids
mortality
COVID-19 therapeutics
immunomodulatory treatment
meta-analysis
updated
bamlanivimab
etesevimab
hospital admission
thromboembolism
tocilizumab
hydroxycholoroquine
immunomodulation
anticoagulation
dose
thromboprophylaxis
treatment
lung ultrasound
COVID-19 pneumonia
imaging
radiology
computed tomography
safety
adverse events
acute kidney injury
nephrotoxicity
antibiotics
antibacterial agents
mixed methods
qualitative
quantitative
mucormycosis
fungal infection
risk factors
diagnosis
therapeutics
omicron
coronavirus disease 2019
monoclonal antibodies
Casirivimab plus imdevimab
Sotrovimab
bebtelovimab
molnupiravir
paxlovid
evusheld
Anakinra
timeline
n/a
long COVID
SPECT
HR-CT scan
lung function test
dosage
biomarker
Krebs von den Lungen-6
severity
children
pandemic
waves
hospitalization
clinical presentation
coronavirus
steroids
early remdesivir
ritonavir-boosted nirmatrelvir
sotrovimab
hematological patients
hospitalizations rate
prolonged viral shedding
bromhexine
standard of care
viral load
primary care
SARS-CoV-2 vaccine
cellular response
CKD
humoral responses
thrombosis
risk prediction model
clinical prediction rule
Coronavirus Disease-2019 (COVID-19)
post-acute sequelae of SARS CoV-2 (PASC, long COVID, post-COVID conditions)
phenome-wide association study
phenotype risk score
electronic health records
post-acute sequelae
sex hormones
age
antibodies
cellular immunity
humoral immunity
INF-γ release assay
mRNA vaccine
machine learning
gradient boosting classifier
reinfection
taste dysfunction
smell perception
central nervous system
predictors of mortality
thema EDItEUR::M Medicine and Nursing
COVID-19: Clinical Advances and Challenges
title COVID-19: Clinical Advances and Challenges
title_full COVID-19: Clinical Advances and Challenges
title_fullStr COVID-19: Clinical Advances and Challenges
title_full_unstemmed COVID-19: Clinical Advances and Challenges
title_short COVID-19: Clinical Advances and Challenges
title_sort covid 19 clinical advances and challenges
topic COVID-19
SARS-CoV-2
ciclesonide
inhalation
antiviral agents
remdesivir
pneumonia
non-invasive ventilation
mechanical ventilation
COVID-19 vaccine
ChAdOx1-S
BNT162b2
immunogenicity
anakinra
baricitinib
corticosteroids
mortality
COVID-19 therapeutics
immunomodulatory treatment
meta-analysis
updated
bamlanivimab
etesevimab
hospital admission
thromboembolism
tocilizumab
hydroxycholoroquine
immunomodulation
anticoagulation
dose
thromboprophylaxis
treatment
lung ultrasound
COVID-19 pneumonia
imaging
radiology
computed tomography
safety
adverse events
acute kidney injury
nephrotoxicity
antibiotics
antibacterial agents
mixed methods
qualitative
quantitative
mucormycosis
fungal infection
risk factors
diagnosis
therapeutics
omicron
coronavirus disease 2019
monoclonal antibodies
Casirivimab plus imdevimab
Sotrovimab
bebtelovimab
molnupiravir
paxlovid
evusheld
Anakinra
timeline
n/a
long COVID
SPECT
HR-CT scan
lung function test
dosage
biomarker
Krebs von den Lungen-6
severity
children
pandemic
waves
hospitalization
clinical presentation
coronavirus
steroids
early remdesivir
ritonavir-boosted nirmatrelvir
sotrovimab
hematological patients
hospitalizations rate
prolonged viral shedding
bromhexine
standard of care
viral load
primary care
SARS-CoV-2 vaccine
cellular response
CKD
humoral responses
thrombosis
risk prediction model
clinical prediction rule
Coronavirus Disease-2019 (COVID-19)
post-acute sequelae of SARS CoV-2 (PASC, long COVID, post-COVID conditions)
phenome-wide association study
phenotype risk score
electronic health records
post-acute sequelae
sex hormones
age
antibodies
cellular immunity
humoral immunity
INF-γ release assay
mRNA vaccine
machine learning
gradient boosting classifier
reinfection
taste dysfunction
smell perception
central nervous system
predictors of mortality
thema EDItEUR::M Medicine and Nursing
topic_facet COVID-19
SARS-CoV-2
ciclesonide
inhalation
antiviral agents
remdesivir
pneumonia
non-invasive ventilation
mechanical ventilation
COVID-19 vaccine
ChAdOx1-S
BNT162b2
immunogenicity
anakinra
baricitinib
corticosteroids
mortality
COVID-19 therapeutics
immunomodulatory treatment
meta-analysis
updated
bamlanivimab
etesevimab
hospital admission
thromboembolism
tocilizumab
hydroxycholoroquine
immunomodulation
anticoagulation
dose
thromboprophylaxis
treatment
lung ultrasound
COVID-19 pneumonia
imaging
radiology
computed tomography
safety
adverse events
acute kidney injury
nephrotoxicity
antibiotics
antibacterial agents
mixed methods
qualitative
quantitative
mucormycosis
fungal infection
risk factors
diagnosis
therapeutics
omicron
coronavirus disease 2019
monoclonal antibodies
Casirivimab plus imdevimab
Sotrovimab
bebtelovimab
molnupiravir
paxlovid
evusheld
Anakinra
timeline
n/a
long COVID
SPECT
HR-CT scan
lung function test
dosage
biomarker
Krebs von den Lungen-6
severity
children
pandemic
waves
hospitalization
clinical presentation
coronavirus
steroids
early remdesivir
ritonavir-boosted nirmatrelvir
sotrovimab
hematological patients
hospitalizations rate
prolonged viral shedding
bromhexine
standard of care
viral load
primary care
SARS-CoV-2 vaccine
cellular response
CKD
humoral responses
thrombosis
risk prediction model
clinical prediction rule
Coronavirus Disease-2019 (COVID-19)
post-acute sequelae of SARS CoV-2 (PASC, long COVID, post-COVID conditions)
phenome-wide association study
phenotype risk score
electronic health records
post-acute sequelae
sex hormones
age
antibodies
cellular immunity
humoral immunity
INF-γ release assay
mRNA vaccine
machine learning
gradient boosting classifier
reinfection
taste dysfunction
smell perception
central nervous system
predictors of mortality
thema EDItEUR::M Medicine and Nursing
url ONIX_20240514_9783036598390_46